Carotid Intima Media Thickness and Its Association With Total Bilirubin Levels in Patients With Coronary Artery Ectasia

Angiology

Volumn 71, Issue 5, 2020, Pages 425-430

  Demirkol, Sait ^a   Balta, Sevket ^a   Celik, Turgay ^a   Unlu, Murat ^b   Arslan, Zekeriya ^c   Cakar, Mustafa ^a   Kucuk, Ugur ^a   Iyisoy, Atila ^a   Barcin, Cem ^a   Demirbas, Seref ^a   Kocak, Necmettin ^a   Cayci, Tuncer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Beytepe Hospital   (Turkey)

^c Gelibolu Hospital   (Turkey)

Author keywords

atherosclerosis; carotid intima media thickness; coronary artery ectasia; total bilirubin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD CELL COUNT; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY ECTASIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 85083223890     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712473796     Document Type: Article

References (37)

1. Swaye P, Fisher L, Litwin P, et al. Aneurysmal coronary artery disease. Circulation. 1983;67:134–38.
2. Swanton R, Lea Thomas M, Coltarte D, Jenkins B, Webb-Peploe MM, Williams B. Coronary artery ectasia, a variant of occlusive coronary arteriosclerosis. Br Heart J. 1978;40:393–400.
3. Hartnell G, Parnell B, Pridie R., Coronary artery ectasia. Its prevalence and clinical significance in 4993 patients. Br Heart J. 1985;54:392–95.
4. Markis J, Joffe C, Cohn P, Feen D, Herman M, Gorlin R. Clinical significance of coronary artery ectasia. Am J Cardiol. 1976;37:217–22.
5. Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–46.
6. Wu T, Fung K, Yang C. Unconjugated bilirubin inhibits the oxidation of human low-density lipoprotein better than Trolox. Life Sci. 1994;54:477–81.
7. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915–24.
8. Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184:431–37.
9. DeRouen TA, Murray JA, Owen W. Variability in the analysis of coronary arteriograms. Circulation. 1977;55:324–28.
10. Antoniadis A, Chatzizisis Y, Giannoglou G. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol. 2008;28:335–43.
11. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169:203–14.
12. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–406.
13. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The atherosclerosis risk in communities (ARIC) study. Stroke. 1995;26:386–91.
14. Celik S, Erdoğan T, Kasap H, et al. Carotid intima-media thickness in patients with isolated coronary artery ectasia. Atherosclerosis. 2007;190:385–87.
15. Ishizu T, Ishimitsu T, Kamiya H, et al. The correlation of irregularities in carotid arterial intima-media thickness with coronary artery disease. Heart Vessels. 2002;17:1–6.
16. Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999;13:295–309.
17. Ross R. Atherosclerosis –an inflammatory disease. N Engl J Med. 1999;340:26.
18. Vıtek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449–56.
19. Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med. 2011;49:1823–28.
20. Zhang ZY, Bian LQ, Kim SJ, Zhou CC, Choi YH. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol. 2012;35:301–6.
21. Erdogan T, Çiçek Y, Altan Kocaman S, et al. Increased serum bilirubin level is related to good collateral development in patients with chronic total coronary occlusion. Intern Med. 2012;51:249–55.
22. Kim KM, Kim BT, Park SB, Cho DY, Je SH, Kim KN. Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans. Arch Med Res. 2012;43:288–93.
23. Yoshino S, Hamasaki S, Ishida S, et al. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb. 2011;18:403–12.
24. McArdle PF, Whitcomb BW, Tanner K, Mitchell BD, Shuldiner AR, Parsa A. Association between bilirubin and cardiovascular disease risk factors: using mendelian randomization to assess causal inference. BMC Cardiovasc Disord. 2012;12:16.
25. Gullu H, Erdogan D, Tok D, et al. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol. 2005;25:2289–94.
26. Tanaka M, Fukui M, Tomiyasu K, et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis. 2009;206:287–91.
27. Breimer LH, Mikhailidis DP. Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target? Cur Pharm Des. 2011;17:3644–55.
28. Breimer L, Wannamethee G, Ebrahim S, Khoo J, Witztum J. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995;41:1504–8.
29. Schwertner H, Jackson W, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40:18–23.
30. Krijgsman B, Papadakis JA, Ganotakis ES, Mikhailidis DP, Hamilton G. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol. 2002;21:44–52.
31. Ghem C, Sarmento-Leite REG, de Quadros AS, Rossetto S, Gottschall C a M. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J. 2010;51:86–91.
32. Wei S, Gao C, Wei G, Chen Y, Zhong L, Li X. The level of serum bilirubin associated with coronary lesion types in patients with coronary artery disease. J Cardiovasc Med (Hagerstown). 2012;13;432–38.
33. Sahin O, Akpek M, Elcik D, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology. 2012;64:200–4.
34. Kuwano T, Miura SI, Shirai K, et al. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 201118:574–83.
35. Hopkins P, Wu L, Hunt S, James B, Vincent G, Williams R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16:250–55.
36. Lin JP, O’Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114:1476–81.
37. Turhan H, Erbay AR, Yasar AS, Balci M, Bicer A, Yetkin E. Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. Am J Cardiol. 2004;94:1303–6.